MSC-Based Cell Therapy in Neurological Diseases: A Concise Review of the Literature in Pre-Clinical and Clinical Research
- PMID: 38785945
- PMCID: PMC11117494
- DOI: 10.3390/biom14050538
MSC-Based Cell Therapy in Neurological Diseases: A Concise Review of the Literature in Pre-Clinical and Clinical Research
Abstract
Mesenchymal stem cells (MSCs) are multipotent stromal cells with the ability to self-renew and multi-directional differentiation potential. Exogenously administered MSCs can migrate to damaged tissue sites and participate in the repair of damaged tissues. A large number of pre-clinical studies and clinical trials have demonstrated that MSCs have the potential to treat the abnormalities of congenital nervous system and neurodegenerative diseases. Therefore, MSCs hold great promise in the treatment of neurological diseases. Here, we summarize and highlight current progress in the understanding of the underlying mechanisms and strategies of MSC application in neurological diseases.
Keywords: MSCs; animal studies; neurological diseases.
Conflict of interest statement
The authors declare no conflicts of interest. This manuscript has not been published before and is not being considered for publication elsewhere.
Similar articles
-
Neurorestoration induced by mesenchymal stem cells: potential therapeutic mechanisms for clinical trials.Yonsei Med J. 2012 Nov 1;53(6):1059-67. doi: 10.3349/ymj.2012.53.6.1059. Yonsei Med J. 2012. PMID: 23074102 Free PMC article. Review.
-
Therapeutic potential of mesenchymal stem cells for diabetes.J Mol Endocrinol. 2017 Oct;59(3):R109-R120. doi: 10.1530/JME-17-0117. Epub 2017 Jul 24. J Mol Endocrinol. 2017. PMID: 28739632 Free PMC article. Review.
-
Concise Review: Quantitative Detection and Modeling the In Vivo Kinetics of Therapeutic Mesenchymal Stem/Stromal Cells.Stem Cells Transl Med. 2018 Jan;7(1):78-86. doi: 10.1002/sctm.17-0209. Epub 2017 Dec 6. Stem Cells Transl Med. 2018. PMID: 29210198 Free PMC article. Review.
-
Mesenchymal stem cells: new approaches for the treatment of neurological diseases.Curr Stem Cell Res Ther. 2010 Dec;5(4):326-44. doi: 10.2174/157488810793351631. Curr Stem Cell Res Ther. 2010. PMID: 20528757 Review.
-
The Anti-Inflammatory Properties of Mesenchymal Stem Cells in Epilepsy: Possible Treatments and Future Perspectives.Int J Mol Sci. 2020 Dec 18;21(24):9683. doi: 10.3390/ijms21249683. Int J Mol Sci. 2020. PMID: 33353235 Free PMC article. Review.
Cited by
-
Magnetic nanoparticles influence the biological function of mesenchymal stem cells.Sci Rep. 2025 Jul 30;15(1):27862. doi: 10.1038/s41598-025-13083-3. Sci Rep. 2025. PMID: 40739120 Free PMC article.
-
Exploring the Potential of Moringa oleifera in Managing Bone Loss: Insights from Preclinical Studies.Int J Med Sci. 2025 Jan 21;22(4):819-833. doi: 10.7150/ijms.103241. eCollection 2025. Int J Med Sci. 2025. PMID: 39991771 Free PMC article. Review.
-
Inhibition of TGF-β signaling enhances osteogenic potential of iPSC-derived MSCs.Sci Rep. 2025 Mar 6;15(1):7814. doi: 10.1038/s41598-025-89370-w. Sci Rep. 2025. PMID: 40050624 Free PMC article.
-
Advancements in Stem Cell Research for Effective Therapies Against Alzheimer's Disease: Current Investigation and Future Insight.Mol Neurobiol. 2025 May 6. doi: 10.1007/s12035-025-05003-3. Online ahead of print. Mol Neurobiol. 2025. PMID: 40327307 Review.
-
Mesenchymal stem cell-derived cell-free technologies: a patent landscape.Biotechnol Lett. 2024 Oct;46(5):907-924. doi: 10.1007/s10529-024-03506-y. Epub 2024 Jun 20. Biotechnol Lett. 2024. PMID: 38900338 Review.
References
-
- Esquerda-Canals G., Montoliu-Gaya L., Güell-Bosch J., Villegas S. Mouse Models of Alzheimer’s Disease. J. Alzheimer’s Dis. JAD. 2017;57:1171–1183. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical